重症COVID-19期间血小板肺内周转的时间依赖性变化
本研究为在大型大学医院ICU开展的队列研究,对31例接受有创或无创机械通气的重症COVID-19患者重复测量动脉与中心静脉血小板计数,无干预。发现动静脉血小板差值与症状出现后时间呈显著正相关,提示早期为负差值(肺内清除血小板)、后期为正差值(肺内释放血小板)。但多数个体动静脉血小板差值小于分析变异系数,作者认为个体层面差值过小,无法据此判断肺内血小板清除与释放。
要点
- 31例重症COVID-19机械通气患者重复测量动静脉血小板差值,发现差值与症状出现后时间呈显著正相关。
- 早期症状阶段动静脉血小板差值为负,提示肺内清除循环血小板,与免疫血栓形成假说一致。
- 后期阶段动静脉血小板差值为正,提示肺内释放血小板恢复,与正常肺功能恢复一致。
- 多数个体动静脉血小板差值小于分析变异系数,作者认为个体层面差值过小,无法判断肺内血小板清除与释放。
适用人群与场景
- 大型大学医院ICU收治的31例重症COVID-19患者,接受有创或无创机械通气。
研究设计与关键结果
- 研究类型为队列研究,重复测量动脉与中心静脉血小板计数,无干预;样本量31例,单中心ICU。
- 动静脉血小板差值与症状出现后时间呈显著正相关,提示早期负差值(肺内清除血小板)、后期正差值(肺内释放血小板)。
- 多数个体动静脉血小板差值小于分析变异系数。
证据类型、等级与局限
- 证据类型:队列研究(重复测量设计),无干预。
- 局限:多数个体动静脉血小板差值小于分析变异系数,作者认为个体层面差值过小,无法据此判断肺内血小板清除与释放。
对床旁实践的改变
- 作者认为,重症COVID-19早期阶段以免疫血栓形成导致肺内清除循环血小板为特征,后期阶段以肺内血小板释放恢复正常为特征。
- 作者认为,多数情况下动静脉血小板差值过小,无法在个体层面判断肺内血小板清除与释放。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES BACKGROUND: Under normal conditions, pulmonary megakaryocytes are an important source of circulating thrombocytes, causing thrombocyte counts to be higher in arterial than venous blood. In critical COVID-19, thrombocytes may be removed from the circulation by the lungs because of immunothrombosis, possibly causing venous thrombocyte counts to be higher than arterial thrombocyte counts. In the present study, we investigated time-dependent changes in pulmonary turnover of thrombocytes during critical COVID-19 by measuring arteriovenous thrombocyte differences. We hypothesized that the early stages of the disease would be characterized by a net pulmonary removal of circulating thrombocytes because of immunothrombosis and that later stages would be characterized by a net pulmonary release of thrombocytes as normal pulmonary function is restored.
DESIGN: Cohort study with repeated measurements of arterial and central venous thrombocyte counts.
SETTING: ICU in a large university hospital.
PATIENTS: Thirty-one patients with critical COVID-19 that were admitted to the ICU and received invasive or noninvasive mechanical ventilation.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We found a significant positive association between the arteriovenous thrombocyte difference and time since symptom debut. This finding indicates a negative arteriovenous thrombocyte difference and hence pulmonary removal of thrombocytes in the early stages of the disease and a positive arteriovenous thrombocyte difference and hence pulmonary release of thrombocytes in later stages. Most individual arteriovenous thrombocyte differences were smaller than the variance coefficient of the analysis.
CONCLUSIONS: The results of this study support our hypothesis that early stages of critical COVID-19 are characterized by pulmonary removal of circulating thrombocytes because of immunothrombosis and that later stages are characterized by the return of normal pulmonary release of thrombocytes. However, in most cases, the arteriovenous thrombocyte difference was too small to say anything about pulmonary thrombocyte removal and release on an individual level.
参考来源
- Aarskog NR, Hallem R, Godhavn JS, et al. Time-Dependent Changes in Pulmonary Turnover of Thrombocytes During Critical COVID-19. Crit Care Explor. 2024. PMID: 39022800. doi:10.1097/CCE.0000000000001128
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。